within 30 min of operon induction, and this rapid change contrasted with the smaller, slower decreases in growth observed when culture optical density was measured. The observation that a change in capacity preceded a change in growth rate after induction ( Supplementary Fig. 2 ) supports the view that decreased expression resources cause a decline in growth rate and underlines the value of this approach.
within 30 min of operon induction, and this rapid change contrasted with the smaller, slower decreases in growth observed when culture optical density was measured. The observation that a change in capacity preceded a change in growth rate after induction ( Supplementary Fig. 2 ) supports the view that decreased expression resources cause a decline in growth rate and underlines the value of this approach.
Next we developed a plate-based burden assay to measure the performance of synthetic constructs in DH10B and MG1655 E. coli (Fig. 1b) . This assay, which compares the capacity of empty plasmids to that of plasmids containing construct parts, can be used to quantify the effects of induced and uninduced constructs and determine how construct composition is related to burden (Fig. 1c) . In both DH10B and MG1655 cells, capacity was decreased by the presence of plasmids and decreased further as DNA constructs were added. Decreases in capacity in both strains led to subsequent growth-rate decreases of similar magnitude ( Supplementary  Fig. 3 ), and the effect on capacity varied substantially depending on the strain used and the size and function of the genes being expressed (Fig. 1d) . The induction of plasmid-encoded AraC was associated with a cost to DH10B cells but not to MG1655 cells, presumably because of the different genotypes of these strains (multiple arabinose operon genes are deleted in the DH10B strain). The assay also allowed for the assessment of interchangeable parts, so that different design options could be compared. AraC-based regulation imparted a lesser burden than the TetR, LuxR and LacI transcriptional regulators, and RNA-based regulation-for example, with an inducible riboswitch-was even less costly to the cell, because fewer resources were required for its operation ( Supplementary  Fig. 4 and Supplementary Notes 1 and 2).
We next investigated whether constructs could be redesigned to reduce their effect on capacity. We used the capacity monitor to assess a library of inducible constructs that express a large protein with no function in our cells, the Chromobacterium violaceum enzyme VioB fused to mCherry. Using parts and design tools developed to enable predictable tuning of gene expression, we varied the VioB-mCherry output within the library by changing the plasmid copy number, the core promoter and the strength of the ribosome-binding site (RBS) and by using E. coli codonoptimized and codon-de-optimized versions of the VioB coding sequence (see Supplementary Fig. 5 and Online Methods for full details). Using the capacity monitor assay, we quantified the burden placed on DH10B cells while simultaneously measuring the construct output as the rate of red fluorescence production per cell (Fig. 2a) . The same analysis was also performed for MG1655 cells (Supplementary Fig. 6 ). In both cases all constructs displayed low output with high capacity and growth when uninduced, except construct H1, which had leaky promoter repression. heterologous gene expression can be a significant burden for cells. here we describe an in vivo monitor that tracks changes in the capacity of Escherichia coli in real time and can be used to assay the burden imposed by synthetic constructs and their parts. We identify construct designs with reduced burden that predictably outperformed less efficient designs, despite having equivalent output.
Quantifying cellular capacity identifies gene expression designs with reduced burden
Robust expression of heterologous genes is necessary for many applications in biotechnology and is central to synthetic biology, where predictable fine-tuning of expression is typically desired [1] [2] [3] . However, for engineered bacteria, all heterologous expression represents an unnatural load, consuming cellular resources and leading to decreased growth rates that can predispose synthetic constructs to evolutionary instability and unexpectedly alter their behavior [4] [5] [6] [7] [8] [9] [10] . This gene expression burden is largely an unquantified phenomenon, typically inferred from declining growth rates 5, 6, 11 or in vitro measurement using cell-free extracts 12 . Despite new models of bacterial growth that underline the importance of expression resources for cells [13] [14] [15] , a method for in vivo quantification of the burden placed on these resources has been lacking.
We developed a fluorescence-based method that allowed us to measure the gene expression capacity of bacterial cells in real time. We inserted a 'capacity monitor' , a synthetic constitutive green fluorescent protein (GFP) expression cassette, into defined genomic loci of commonly used E. coli strains (Supplementary Fig. 1 ), reasoning that because this cassette lacks regulation, changes in GFP expression due to global expression changes would reflect changes in resource availability 16 . To first demonstrate that this method is an improvement over the use of growth rates to assess burden, we measured the effect of inducing expression of a plasmid-based operon at different time points during exponential growth of DH10B E. coli containing the capacity monitor (Fig. 1a) . Capacity (determined as the GFP production rate per cell) was substantially reduced compared to that of uninduced cells A variety of different outputs were measured 1 h after induction. Generally, greater output was matched by decreased capacity, and the measured capacity correlated strongly with the growth rate (Fig. 2b) . In contrast, a precise inverse correlation between construct output and cell capacity was not observed (Fig. 2c) ; this revealed that some designs proportionally took up a greater amount of a host cell's capacity per construct output (for example, construct M1) and were therefore less efficient for the cell, where 'efficiency' defines a measure of simultaneous maximization of both construct output and cell capacity.
In our construct library, all of the inefficient designs had a strong RBS (Fig. 2c) . To verify that RBS strength was the cause of the inefficiency, we also characterized constructs with an alternative 5′ UTR strong-RBS sequence, and this gave equivalent results (Supplementary Fig. 7 ). The significance of the RBS in determining burden in our study supports previous work highlighting cells' translational resources, particularly the 'free ribosome pool' , as the critical factor for optimal cell growth and gene expression 14, 15, 17 . To test this hypothesis mathematically and to guide the design of efficient gene expression constructs, we implemented a translation model of heterologous expression that takes into account ribosome availability 18 . This model describes the steps of translation initiation, elongation and ribosome release along a translating mRNA when the number of available ribosomes is finite. 
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Luc sCG Lux Luc sCG coli when expression of a six-gene Vibrio luciferase (Lux) operon from a high-copy plasmid was induced at two independent time points (0 and 120 min, marked by orange and red arrows, respectively) during 4.5 h of exponential growth. DH10B-GFP had the capacity monitor integrated into the genome at the λ locus; DH10B was the unmodified parent strain. Capacity was determined by the change in total GFP production per cell over 1 h (GFP h −1 , a.u.), and growth was determined by the optical density at 600 nm (OD 600 ). Each dot represents three technical repeats, and lines were plotted between mean values. 
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This model was used to simulate in vivo gene expression via a Python script described in Supplementary Note 3 and provided as Supplementary Software. The effects of variation in the amount of mRNA (adjustable through changes in promoter strength and/or plasmid copy number), the RBS strength and the translation rate (adjustable by codon choice) were explored. Even though the model accounted only for effects on shared translational resources, it was able to predict the burden phenotypes that we observed experimentally where construct output and capacity monitor expression changed as the construct design was modified (Supplementary Fig. 8 ). The model also described how rare codons or other sequences that slowed translation elongation affected only designs with a strong RBS (Supplementary Fig. 9 ), and this qualitatively matched the experimental data collected for de-optimized VioB (Fig. 2a) . Importantly, the model allowed for simulation of the available design space of a construct to determine the designs with the greatest simulated expression efficiency (i.e., those with the greatest construct output for the least use of ribosomes) ( Fig. 2d and Supplementary Fig. 10 ). Both the burden assay (Fig. 2a) and these simulated data predicted that a high-copy, weak-RBS construct (H3) would be more efficient than a medium-copy, strong-RBS construct (M1) with similar output levels, despite the fact that the former requires more construct DNA and mRNA per cell. Greater efficiency should result in faster, more robust growth of cells and thus greater construct output from batch growth. To verify this prediction, we scaled up the expression of H3 and M1 constructs to 50-ml shake-flask scale and measured the total output after overnight induction (Fig. 2e) . In both DH10B and MG1655 cells, the total output was substantially greater at any time point when H3 was used instead of M1. This was largely due to faster growth of H3-expressing cultures, but it was also due to escape mutations occurring in M1 cultures that led to the growth of cells with no construct output ( Supplementary Figs. 11 and 12) . These results showed that expression designs imposing reduced burdens had greater yields and superior genetic stability. Importantly, the underlying model relies on generic assumptions that typically hold true in various contexts 18 . As a test of its predictive use, we used the same model to correctly predict the effects on cell capacity and construct output of expressing an unrelated short protein 
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Growth rate (h The capacity monitor enables assessment of the effects caused by different parts, and this information can be used to reduce the burden of further designs. In contrast to the specific burden caused by protein function, the burden assessed here is a general cost associated with all heterologous expression. Our work suggests that when two different constructs perform similar tasks, the design that maintains the most free ribosomes for the cell will impart the least burden. Avoiding 'overinitiation' of translation is thus an important design rule for synthetic biology 19 , and circuits that avoid unnecessary protein expression (e.g., RNA-based regulation 20 or biological analog circuits 21 ) should outperform equivalent circuits made from transcription-factor logic gates 22 . Furthermore, constructs that write the memory of events into genomic DNA 23 may also be less burdensome than established bistable switches that require continual transcription-factor expression to maintain memory 24 .
Measuring capacity in alternative strains can also reveal genotype-specific differences in burden that might aid in the selection of an optimal host for heterologous expression. We believe that the main burden of gene expression is simply a result of gene expression resource depletion, which has the greatest impact on cells growing at close to their maximum rate. As such depletion is a fundamental process common to all dividing cells, it is likely that this work could be extended beyond E. coli and be applied to other rapidly dividing organisms, such as Saccharomyces cerevisiae. The vectors we provide for capacity monitor integration can be used in other bacteria with compatible att loci 25 , and the accompanying Python script for translation simulation is general and therefore appropriate for broad use. comPeting financial interestsonline methods Bacterial strains and DNA constructs. Strains MG1655 (K-12 F-λ-rph-1) and DH10B (K-12 F-λ-araD139 ∆(araA-leu)7697 ∆(lac)X74 galE15 galK16 galU hsdR2 relA rpsL150(Str R ) spoT1 deoR φ80dlacZ∆M15 endA1 nupG recA1 e14-mcrA ∆(mrr hsdRMS mcrBC)) were obtained from the National BioResource Project (NBRP) Japan. All synthetic genes were codon-optimized for efficient expression in E. coli by DNA2.0. RBS sequences were designed using RBS Calculator software provided by Denovo DNA. The capacity monitor cassette consisted of a synthetic strong constitutive promoter, a synthetic RBS, a codon-optimized superfolder GFP 26 coding sequence and a synthetic unnatural bidirectional terminator (Supplementary Fig. 1 and Supplementary Table 1 25 and selecting with 50 µg/ml kanamycin (Supplementary Fig. 1 ). Subsequent capacity monitor-containing strains (all λ-integrated in this study) could be propagated without selection and transformed with construct plasmids for testing by electroporation. Details of the design, acquisition and construction of all control and construct plasmids assessed with the capacity monitor in this study are provided below.
Characterized expression constructs. The three expression constructs giving inducible heterologous gene expression are illustrated in Supplementary Table 2 and were all obtained via the iGEM Parts Registry (http://parts.igem.org/Catalog) on the high-copy, chloramphenicol-selectable pSB1C3 plasmid. The Lux operon (BBa_K325909: AraC-pBAD-LuxCDABEG) and Luc operon (BBa_K325219: AraC-pBAD-LRE-Luc) encode L-arabinose-inducible expression of six luciferase-related Vibrio fischeri genes and two luciferase-related Luciola cruciata genes, respectively. For both, all operon genes were codon-optimized for E. coli by DNA2.0 for the Cambridge 2010 iGEM team. We constructed the sCG operon (AraC-pBAD-sCG) by replacing the Luc operon genes in the aforementioned construct with a synthetic gene encoding the human chorionic gonadotropin β-subunit that had been codon-optimized for expression in bacteria by the Virginia 2012 iGEM team. The regulatorpromoter-only control construct (AraC-pBAD) was generated by restriction digestion and re-ligation of the Luc construct to remove the operon genes. Further controls were the highcopy, chloramphenicol-selectable pSB1C3 plasmid; the low-copy, chloramphenicol-selectable pSB4C5 plasmid; and the high-copy, ampicillin-selectable pSB1A2 plasmid 27 .
Inducible-expression constructs. Three alternative inducibleexpression cassette constructs were prepared ( Supplementary  Fig. 4a ) using parts taken from the iGEM Parts Registry (Supplementary Table 3) . Lux Inverter BioBrick BBa_F2620 encoding pTet-LuxR-pLux on high-copy plasmid pSB1C3 was taken directly as previously constructed and described 28 . To obtain a similar construct for TetR regulation (pLac-TetR-pTet), we amplified device BBa_I732913 by PCR to take all parts from the pLacIq promoter (upstream of TetR) to the pTet promoter (i.e., excluding mRFP) and placed it on high-copy plasmid pSB1A2 using cloning by the Gibson assembly method 29 . To obtain an equivalent LacI-regulated construct (p105-LacI-pLac), we used standard BioBrick and Gibson assembly to place a constitutive promoter (BBa_J23105), the LacI coding sequence (CDS) (BBa_C0012) with appropriate RBS (BB_B0034), a transcriptional terminator (BBa_B0015) and the pLac promoter (BBa_R0010), in that order, within high-copy plasmid pSB1A2. All constructs were verified by analytical gel digestion before use. To induce the TetR regulator, we added anhydrotetracycline to culture at a final concentration of 100 ng/ml. For the LacI regulator, induction was achieved with isopropyl β-D-1-thiogalactopyranoside at a final concentration of 1 mM. For the LuxR regulator, induction was achieved with acyl-homoserine lactone at a final concentration of 30 nM. Supplementary Figure 4b , constructs containing the theophylline riboswitch (pLac-Riboswitch and pLac-Riboswitch-mRFP) were custom synthesized as GeneStrings by GeneArt, cloned into pSB1A2 and sequence verified (Supplementary Table 4 ). The sequences of the pLac promoter and mRFP CDS were kept identical to those in pLac-TetR-pTet (Supplementary Fig. 4a) , and the riboswitch sequence was as previously described 30 . The pLac-TetR-pTet-mRFP construct was the aforementioned BBa_ I732913 device cloned into pSB1A2. All constructs were verified by analytical gel digestion and DNA sequencing before use. To induce the TetR regulator, we added anhydrotetracycline to culture at a final concentration of 100 ng/ml. To induce the riboswitch, we added theophylline to culture at a final concentration of 2 mM.
Riboswitch constructs. For the measurements presented in
Burden assay and time course. For the burden assay (Fig. 1b) , E. coli cells with and without plasmid constructs were grown at 37 °C overnight with aeration in a shaking incubator in 5 ml of defined supplemented M9 media with the appropriate antibiotic. In the morning, 20 µl of each sample was diluted into 1 ml of fresh medium and grown at 37 °C with shaking for another hour (outgrowth). We then transferred 200 µl of each sample at approximately 0.1 OD 600 into a 96-well plate (Costar), placed samples in a Synergy HT Microplate Reader (BioTek) and incubated them at 37 °C with orbital shaking at 1,000 rpm for 3 h, performing measurements of GFP (excitation (ex.), 485 nm; emission (em.), 528 nm), RFP (ex., 590 nm; em., 645 nm) and OD (600 nm) every 30 min. 60 min into the incubation, the plate was briefly removed so inducer could be added to wells, and this time point was set as time 0 (t 0 ). All burden assays were repeated independently on three different days, and to avoid inhibition of arabinose-induced expression due to catabolite repression, 0.4% fructose was used as the main carbon source. For the burden time-course experiment (Fig. 1a) , the same procedure was applied, but with the 96-well plate prepared with cells initially at 0.02 OD 600 . The plate was then placed into the microplate reader and incubated and measured as described above, with a pregrowth of 60 min to t 0 before 300 min of growth for the time course. L-arabinose was added to appropriate wells at 0 min and 120 min. Final inducer and antibiotic concentrations used in assays were as follows: L-arabinose, 0.2%; ampicillin, 100 µg/ml; and chloramphenicol, 34 µg/ml. npg Data analysis. For the burden assay, growth and protein expression rates per hour were calculated as previously described 5 , with growth rate t2 = ln(OD t3 ) -ln(OD t1 )/(t 3 -t 1 ), GFP expression rate t2 = ((total GFP t3 ) -(total GFP t1 )/(t 3 -t 1 ))/OD t2 , and RFP output rate t2 = (((total RFP t3 ) -(total RFP t1 )/(t 3 -t 1 ))/OD t2 ) + 400, where t 1 = 30 min after induction, t 2 = 60 min after induction and t 3 = 90 min after induction. 400 was added to all RFP output rates to account for the background red fluorescence of M9 media, which decreased at a rate of approximately 400 RFP h −1 as it was consumed by cells during growth. Mean rates and their standard error were determined from the rates measured in independent experiments done on three different days. For the burden time course, we applied the same analysis, but calculating values for 30-min time points over 4.5 h for each sample. Mean OD 600 values and expression rates and their standard deviations were determined from values calculated from three wells of the same plate. To calculate the cost for each step, we calculated the cumulative burden by subtracting the capacity percentage of the construct from that of the construct immediately above it in the table in Figure 1d . For Ara induction, the value was subtracted from the uninduced equivalent. For total cumulative burden (with and without Ara), we compared the percentage decrease in the capacity of the full system (Lux, Luc or sCG) to the capacity of untransformed GFP + cells (100%). Error is expressed as ±% and is calculated from s.d. values.
Construction and design of the VioB-mCherry library.
The AraC-pBAD-VioB-mCherry construct was generated by Gibson assembly 29 of overlapping DNA parts amplified by PCR. Plasmid backbones were amplified from pSB31C3 (high-copy) and from the backbone part of plasmid pLysE (medium-copy; Bioline Taunton). The AraC-pBAD part was amplified from the aforementioned Luc construct, and mCherry was amplified from BioBrick BBa_J06504. The VioB CDS was amplified from BioBrick BBa_K274003 and is the second of four C. violaceum genes in a pigment-producing pathway that were optimized for E. coli expression by DNA2.0 for the Cambridge 2009 iGEM team. VioB is a 110-kb chromopyrrolate synthase protein that catalyzes the conversion of two molecules of 2-imino-3-(indol-3-yl)propanoate into one chromopyrrolate molecule. The MetaCyc database (http://metacyc.org) shows that neither the substrate nor the product for VioB is present in E. coli metabolism, so the enzyme is predicted to be inactive when expressed on its own 31 . In order to fuse VioB and mCherry, we added a sequence encoding an H-linker peptide 32 to 3′ primers used to amplify VioB and 5′ primers used to amplify mCherry. RBS sequences for the VioB-mCherry CDS were designed using the forward-engineering mode of the RBS Calculator 33 and included in 5′ primers amplifying the VioB region and 3′ primers amplifying the AraC-pBAD part. We generated stronger pBAD promoters by incorporating point mutations into the pBAD core promoter region as previously described by the DTU Denmark 2011 iGEM team (Supplementary Table 5) , using inverse PCR of the plasmid with mutation-encoding phosphorylated primers followed by DpnI digestion and re-ligation. To incorporate the de-optimized sequence (see below for design explanation) into the VioB-mCherry CDS, we used circular polymerase extension chain assembly 34 to replace the distal 267 bp of the VioB CDS (upstream of the H-linker) with a 267-bp gBlock DNA fragment synthesized by IDT. All PCR amplifications were done using Phusion High Fidelity Polymerase (NEB), all primers were synthesized by IDT, and all enzymes used for digestion and ligation were obtained from NEB. All constructs, whether generated in-house or elsewhere, were verified by analytical gel digestion and DNA sequencing before use.
Designing a de-optimized VioB coding sequence. Previous work has highlighted the role of codon optimization in efficient gene expression 35, 36 ; however, there is no unified view on the mechanisms that lead to reduced translation due to inefficient CDS design. Many support the notion that detrimental sequences in a CDS, related to either codon choice or local mRNA folding, cause ribosomes to pause and create a bottleneck in translation elongation (or a 'ribosome traffic jam') 37 . Some suggest that rare codons (due to the lack of corresponding charged tRNAs) or rare amino acids are responsible for ribosome pausing in conditions of limited resources 36, 38 , whereas others have shown evidence that the presence of anti-Shine-Dalgarno-like sequences in coding regions directly interact with ribosomal RNA and cause ribosomal pausing 39 . Recent work has shown that ribosomal pausing is not a common occurrence in the transcriptome of exponentially growing E. coli 40 , but this is likely because of the very strong evolutionary pressure to remove such pauses from all highly expressed native genes active during fast growth. Heterologous genes that inadvertently incorporate sequences detrimental to the host cell do not have the advantage of evolution to remove such pauses, and instead codon optimization is required.
To investigate the effects of codon optimization, we took the optimized version of the VioB-mCherry construct and recoded 183 bp close to the 3′ end of the VioB coding sequence to contain both rare codons and one instance of the strongest known anti-Shine-Dalgarno-like sequence, AGGAGG. This was done to create a potential translation bottleneck 37, 39, 41 far away from the 5′ end of the gene, where the effect of codon optimization is disputed 36, 42 , and thus effectively de-optimize the construct. In the 183-bp region, all arginine-, isoleucine-, leucine-and proline-encoding codons were exchanged with their equivalent rare E. coli codon, and this also introduced the AGGAGG anti-Shine-Dalgarno-like sequence 39 . Details can be found in Supplementary Table 5 .
Verifying the VioB-mCherry construct library. Following verification by analytical gel digestion and sequencing of parts, the construct library was verified to determine that design changes had led to expected behaviors. To do this, we compared the RFP measurements upon induction for all constructs. The mutated, stronger pBAD promoter showed an approximately 1.5-fold increase in expression relative to the wild-type version, as expected. Expression of constructs on high-copy plasmids gave approximately fivefold greater output compared to equivalents on medium-copy plasmids. Use of the strong RBS gave around threefold greater output than use of the weak RBS. The alternative strong RBS yielded output effectively identical to that of the strong RBS. Note that we assumed that outputs from H1 and H2 were close to saturated maximal output and therefore unreliable for assessing how changing a part increased or decreased expression. Approximations of fold change given here were calculated without consideration of these constructs. No substantial npg change in output was seen when the inefficient VioB-mCherry CDS was introduced into a construct with a weak RBS, but output decreased by 50% when the CDS was introduced into a construct with a strong RBS.
Model simulation. We constructed a model showing how synthetic gene and native host cell processes compete for shared resources by focusing on the process of translation, specifically the shared use of ribosomes. In order to create a model that could depict some of the key processes, we looked carefully at the process of elongation, as ribosomes spend a majority of the translational time in this stage. More details about the mathematical derivations of the translation model can be found in our previous work 18 . A Python script was built that allowed this model to simulate the gene expression burden, and this is described in Supplementary Note 3. This Python script and associated MATLAB scripts for the visualization of results are provided as Supplementary Software and are made available under the Open Source BSD 2-Clause License (http://opensource. org/licenses/BSD-2-Clause).
We simulated our experimental setup by simulating a system in which one construct was the unregulated gene (the monitor) and the other was a heterologous construct. The Python script was used to simulate the experimental results presented in Figure 2a ( Supplementary Fig. 8 ) and to predict the experimental results in Supplementary Figures 13 and 14 . Simulation was done using key parameters obtained from Bionumbers.org (see Supplementary Note 3), along with the relative strengths of the parts used as determined from their experimental characterization. As pBAD is known to be a strong promoter, we assumed each copy of the promoter would produce about 30 copies of mRNA per cell when induced (estimated from Bionumber I.D. 107667). We therefore estimated that the stronger mutated version would give 50 copies per cell. The p15A-origin medium-copy promoter was set at 20 copies per cell, and the pUC-origin high-copy promoter was therefore expected to give 100 copies per cell. This led to mRNA numbers ranging from 600 per cell for induced M2 and M4 constructs to 5,000 per cell for induced H1 and H3 constructs. Parameters for the simulation of construct expression and capacity monitor expression were as follows: total available ribosomes, 10,000; capacity monitor length, 24 (720 bp); capacity monitor mRNAs, 20; capacity monitor RBS strength, 1; capacity monitor elongation rate, 1 throughout; construct length, 100 (3,000 bp) for long-CDS constructs or 30 (900 bp) for short-CDS constructs; construct mRNAs, 100-5,000; construct RBS strength, 0.1-10; optimized construct elongation rate, 1 throughout; de-optimized elongation rate for long CDS, 1 for steps 1-79 and steps 90-100, but 0.5 for steps 80-89; un-optimized elongation rate for short CDS, 1 for all steps from 1 to 30, except for steps 6, 14, 20 and 26, which had an elongation rate of 0.5.
To determine the efficiency of the design space (Fig. 2d) , we performed simulations of all different mRNA numbers (steps of 100 from 100 to 5,000) and RBS strengths (steps of 0.1 from 0.1 to 10) and generated a heat map of efficiency at steady state with our MATLAB script, calculating the normalized expression efficiency as the product of the simulated construct output and the simulated free ribosomes and normalizing all calculated values of expression efficiency to the maximum value in the simulated design space. Simulated expression efficiency without normalization was also determined and visualized in heat maps alongside equivalent heat maps for the simulated circuit output (Supplementary Fig. 10 ).
Shake-flask-scale growth. Constructs H3 and M1 were assessed in DH10B and MG1655 E. coli over 24 h of exponential growth in media with inducer, and assessments were repeated in full on three consecutive days. Starter cultures of H3-DH10B, H3-MG1655, M1-DH10B and M1-MG1655 from individual colonies taken from a plate were grown at 37 °C with shaking for 5 h in 3 ml of supplemented M9 with 0.4% fructose, 34 µg/ml chloramphenicol. The starter culture for each strain was then diluted to 0.015 OD 600 , and 50 µl of the diluted culture (~150,000 cells) was used to inoculate batch cultures of 50 ml supplemented M9 with 0.4% fructose, 0.2% L-arabinose, 34 µg/ml chloramphenicol in 500-ml baffled shake-flasks. Shake-flask cultures were grown with shaking at 37 °C for 16 h, and then 1 ml of culture was removed from each flask every 2 h for 24 h. 200 µl of removed culture was measured for optical density (OD 600 ; Supplementary  Fig. 11a ) and total VioB-mCherry production (RFP output; Fig. 2e ) using the microplate reader. The red fluorescence and green fluorescence (from the capacity monitor) of individual cells in these cultures were simultaneously determined by flow cytometry with a modified Becton Dickinson FACScan flow cytometer capable of parallel measurement of GFP and RFP. Cells were diluted in water and passed through the cytometer for 30 s. A 488-nm laser was used for excitation of green fluorescence, detecting through a 530-nm band-pass filter (FL1-H). For red fluorescence we used a 561-nm laser and a 610-nm filter (FL2-A). Data analysis and presentation (Supplementary Fig. 11b ) were performed in FlowJo (Treestar Inc.), gating forward and side scatter appropriately for E. coli cells.
Plasmid-mutation analysis. Samples from individual colonies were grown with induced expression at 37 °C with shaking for 24 h in 15-ml tubes containing 5 ml of supplemented M9 with 0.4% fructose, 0.2% L-arabinose, 34 µg/ml chloramphenicol and L-arabinose inducer. Samples that reached 0.6 OD 600 or above were screened for red and green fluorescence by flow cytometry before plasmid DNA was extracted by standard miniprep. Plasmid DNA was then sequenced from a forward primer extending from the 5′ end of the pBAD promoter, giving ~900 bases of sequence data covering the pBAD promoter, the RBS and the start of the VioB CDS. Where DNA sequencing failed, analysis of plasmid size was done by gel electrophoresis after restriction digestion.
Single-chain variable fragment constructs. High-copy plasmids expressing a single-chain variable fragment (scFv) gene from AraC-pBAD were constructed for the analyses described in Supplementary Figures 13-15 . For construct assembly, we purchased as DNA GBlocks (IDT) four scFv CDS regions with the same strong synthetic RBS sequence (Supplementary Table 6 ). These were cloned in place of the VioB-mCherry CDS from construct H1 using restriction digestion and ligation to directly swap the RBS CDS regions while maintaining the promoter and plasmid regions. Before assays, all constructs were verified by analytical gel digestion and DNA sequencing. Construct F1 consisted of AraC-pBAD-scFv-A, where scFv-A consisted of a synthetic RBS designed by the RBS Calculator 33 to be strong npg (95,000 a.u.) followed by the optimized A1 scFv CDS previously described as codon optimized 35 . Construct F2 was the equivalent of F1 but contained a previously described (A1_24) nonoptimized version of the scFv CDS that maintains the exact same DNA sequence for the first 45 bp of the CDS 35 . Construct F3 (Supplementary Fig. 15 and Supplementary Note 5) contained the scFv-J CDS designed by the online JCat algorithm 43 (http://www.jcat.de), which uses a codon adaptation index method. Construct F4 contained the scFv-E CDS designed by Eugene (http://bioinformatics.ua.pt/eugene), a freeware suite using a codon harmonization algorithm. An additional scFv CDS designed by the online Optimizer algorithm 44 (http://genomes. urv.es/OPTIMIZER) proved difficult to synthesize and could not be cloned into the appropriate plasmid, so it was not assessed in this study. For constructs F3 and F4, the sequences for scFv-J and scFv-E CDS were obtained by optimizing the scFv-A CDS downstream of the first 45 bp for E. coli K-12. In both cases, two codons within the C-terminal His-tag then had to be manually swapped to remove repetitive sequences prohibiting commercial gene synthesis. The first 45 bp of the CDS were kept identical for all constructs (F1, F2, F3 and F4) to ensure that the same strong RBS could be used for all. A version of construct F1 with a weak RBS (construct F5) was prepared by using site-directed mutagenesis to introduce a single base-pair mutation into the RBS sequence of construct F1 to change its RBS strength to a predicted strength of 9,500 a.u. (calculated by RBS Calculator reverse mode 33 ). Before assays, all constructs were verified by analytical gel digestion and DNA sequencing. The burden assay was performed as before.
Western blot. To verify and measure scFv production, we used western blotting (Supplementary Fig. 15a) . DH10B E. coli containing constructs F1, F2, F3, F4 and F5 were grown overnight at 37 °C in a shaking incubator in 15-ml tubes containing 5 ml of supplemented M9 with 0.4% fructose, 34 µg/ml chloramphenicol. In the morning, each culture was diluted 1:7 into 5 ml of fresh medium with and without induction with 0.2% L-arabinose. After 4 h of growth, OD 600 was measured, and 1 ml of cells diluted to 0.4 OD 600 were harvested. Pellets of these cells were resuspended in 160 µl of distilled water mixed with 40 µl of 6× SDS-PAGE loading buffer. Samples were then denatured by boiling at 94 °C for 10 min. 8 µl of each sample were loaded and separated by 12% SDS-PAGE alongside a positive control sample that verified the antibody functionality (extract from Pichia pastoris GS115 expressing a known single-chain antibody fragment with a C-terminal His-tag) and 5 µl of 10-170 kDa PageRuler Prestained Protein Ladder (Thermo Scientific). Protein was transferred from the gel to membrane (Millipore) using a Trans-Blot SD semi-dry transfer cell (Bio-Rad). Protein detection was performed with an anti-His primary antibody (BioLegends; clone J099B12) and the WesternBreeze Chromogenic Western Blot Immunodetection Kit (Invitrogen). Image analysis of the western blot was performed in ImageJ (NIH) by converting a color photograph of the membrane into grayscale and measuring the maximum and minimum gray intensity in the region immediately at and around each visual band. To calculate the intensity, we subtracted the minimum (local background) from the maximum (band).
